Lei Zhang
Journal of Medical Virology · with Liu · 2020
A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Whom Lei Zhang trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Lei Zhang overall
Papers from Lei Zhang's perspective
Ordered by how strongly the researchers Lei Zhang trusts endorse each paper. Same corpus, a different order for every researcher.
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
- Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan (Emerging Microbes and Infections)
- Vitamin D insufficiency among free-living healthy young adults. (American Journal of Medicine)
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia (New England Journal of Medicine)
- Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV (Nature Communications)
- Effects of chloroquine on viral infections: an old drug against today's diseases (Lancet. Infectious Diseases (Print))
- First Case of 2019 Novel Coronavirus in the United States (New England Journal of Medicine)
- Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. (Journal of the American Medical Association (JAMA))
- Coronavirus envelope protein: current knowledge (Virology Journal)
- Sex-based differences in susceptibility to SARS-CoV infection (Journal of Immunology)
Their papers
- Potential interventions for novel coronavirus in China: A systematic review (2020) — 1,223 citations